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Abstract: Gamma tocopherol (gT) exhibits beneficial cardiovascular effects partly due to 
its anti-inflammatory activity. Important sources of gT are vegetable oils. However, little is 
known to what extent gT can be transferred into marine animal species such as Atlantic 
salmon by feeding. Therefore, in this study we have investigated the transfer of dietary gT 
into salmon. To this end, fish were fed a diet supplemented with 170 ppm gT for 16 weeks 
whereby alpha tocopherol levels were adjusted to 190 ppm in this and the control diet. 
Feeding gT-rich diets resulted in a three-fold increase in gT concentrations in the liver and 
fillet compared to non-gT-supplemented controls. Tissue alpha tocopherol levels were not 
decreased indicating no antagonistic interaction between gamma- and alpha tocopherol in 
salmon. The concentration of total omega 3 fatty acids slightly increased in response to 
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dietary gT. Furthermore, dietary gT significantly decreased malondialdehyde in the fillet, 
determined as a biomarker of lipid peroxidation. In the liver of gT fed salmon we observed 
an overall down-regulation of genes involved in lipid homeostasis. Additionally, gT 
improved the antioxidant capacity by up-regulating Gpx4a gene expression in the pyloric 
caeca. We suggest that Atlantic salmon may provide a marine functional source capable of 
enriching gT for human consumption. 
Keywords: gamma tocopherol; vitamin E; oily fish; salmon (Salmo salar); omega 3 fatty 
acids; functional foods; cardiovascular disease 
 
1. Introduction 
Cardiovascular disease is the leading cause of mortality in the Western world. There is evidence 
that the consumption of oily fish may significantly decrease cardiovascular disease risk in humans [1]. 
Oily fish, such as Atlantic salmon, is an important source of long chain omega 3 fatty acids including 
eicosapentaenoic acid (EPA; C20:5n-3) and docosahexaenoic acid (DHA; C22:6n-3) which may 
exhibit beneficial cardiovascular effects [2–4]. Due to their double bonds, both EPA and DHA are 
prone to lipid peroxidation. Our studies have demonstrated that Vitamin E (alpha tocopherol) 
significantly prevents the oxidation of long chain PUFAs in oily fish [5]. The antioxidant properties of 
Vitamin E result from its phenolic hydroxyl group which donates hydrogen to peroxyl radicals, 
resulting in the formation of relatively stable lipid species [6]. In addition to its antioxidant function, 
important gene-regulatory properties of Vitamin E have been described [7,8]. 
Vitamin E comprises a mixture of four tocopherols which are 6-chromanol derivatives connected to 
an aliphatic side-chain. Individual tocopherols are named according to the position and number of the 
methyl groups on the phenol ring, with the α-, β-, γ- and δ- vitamins containing three, two, two and  
one methyl groups, respectively. These structural differences determine the biological activity  
of tocopherols [6]. 
Gamma tocopherol (gT) occurs at high concentrations in plant-derived oils including soya- and 
rapeseed oil [9,10]. Studies suggest that gT exhibits biological functions which clearly distinguishes it 
from alpha tocopherol [10]. As compared to alpha tocopherol, gT is a more potent scavenger of 
reactive nitrogen species. In this context, it is postulated that gT acts as a trap for electrophilic nitrogen 
oxides forming stable carbon-centered adducts through the nucleophilic 5-position [11]. 
Chronic inflammatory processes are centrally involved in the pathogenesis of cardiovascular diseases. 
Interestingly, gT, but not alpha tocopherol, inhibited cyclooxygenase 2 in cultured macrophages, 
thereby mediating potent anti-inflammatory activity [12]. Furthermore, Jiang and co-workers observed 
a suppression of inducible nitric oxide synthase expression by gT in lipopolysaccharide-challenged 
macrophages [12]. The anti-inflammatory properties of gT in vitro have been subsequently confirmed 
in corresponding in vivo studies in laboratory rodents [13]. 
Plasma concentrations of gT in humans may be inversely associated with cardiovascular disease  
risk [10]. Given the unique functional properties and health benefits of gT, it seems plausible to enrich 
oily fish with gT [14]. While vegetable oils, which are considered an important source of gT, do not 
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contain significant amounts of long chain polyunsaturated fatty acids, oily fish is a source of EPA and 
DHA. Gamma-tocopherol in combination with the fish oils EPA and DHA may act synergistically as 
far as their beneficial cardiovascular activities in humans are concerned. In addition, feeding Atlantic 
salmon with gT might improve fish antioxidant status thereby preventing the oxidation of EPA and 
DHA. This could be a feasible nutritional strategy for the salmon feed industry to maintain high tissue 
EPA and DHA levels in a context of scarce fish oil supply as a raw material for feed production. 
In this study we have aimed to investigate if dietary gT affects tocopherol levels, antioxidant status 
and fatty acid composition of Atlantic salmon as an important source of EPA and DHA and as a 
potential functional source of gT for human nutrition. 
To this end we have measured malondialdehyde (MDA) concentrations as a biomarker of  
lipid peroxidation and sensory quality [15] and carried out fatty acid gas chromatography analyses, 
antioxidant enzyme activity measurements and gene expression analyses of genes involved in fatty 
acid transport, synthesis and metabolism. 
2. Results 
2.1. Fish Performance 
The growth of the fish was divided into two periods, due to detection of the parasite Ichthyobodo in 
the fish after 12 weeks of feeding. Fish were then treated with formalin (30 min bath in 1:4000 ppm of 
35% formalin) and fed for another 4 weeks prior to sampling. There were no differences in specific 
growth rate (SGR) or feed conversion ratio (FCR) before and after the formalin treatment. In the first 
growth period, the fish had an average SGR of 1.19 ± 0.04 and a FCR of 0.81 ± 0.04. In the second 
period after the formalin treatment, the SGR was 1.55 ± 0.07 and the FCR 0.74 ± 0.02. 
2.2. Tissue Levels of Tocopherols, Malondialdehyde, Antioxidant Enzymes and Fatty  
Acid Composition 
In order to evaluate the transfer of Vitamin E from the diet into the tissues of Atlantic salmon we 
determined the gamma and alpha tocopherol concentrations in fish fillet and liver. As summarized in 
Table 1, feeding the gT enriched diet resulted in a three-fold increase of gT concentrations in both 
fillet and liver (p < 0.0001). However, alpha tocopherol levels in fillet and liver were similar between 
the groups indicating no antagonistic interaction between gamma and alpha tocopherol. 
Most methods for analyzing lipid peroxidation in animal tissues lack specificity and sensitivity [16]. 
However, MDA is an important biomarker of lipid peroxidation and may also partly reflect the sensory 
quality of fish [15]. Using a validated HPLC method [17] to measure MDA, we found that MDA 
concentrations were significantly decreased by 25% in the fillet of gT-fed salmon as compared to the 
controls (3.3 ± 0.2 mmol·MDA/kg fillet in the control vs. 2.5 ± 0.2 mmol·MDA/kg fillet in gT-fed 
salmon, p < 0.02). 
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Table 1. Alpha and gamma tocopherol concentrations (μmol/kg) in fillet and liver of Atlantic 
salmon fed either the control diet (C) or a diet enriched with gamma tocopherol (gT) a. 
Tissue C gT p 
Fillet    
α-tocopherol 36.7 ± 3.2 45.3 ± 4.4 0.86 
γ-tocopherol 5.4 ± 0.3 16.3 ± 1.1 <0.0001 
Liver    
α-tocopherol 912 ± 69 937 ± 131 0.15 
γ-tocopherol 34.7 ± 2.4 112.1 ± 9.9 <0.0001 
a Values are means ± SE (n = 8). 
Liver superoxide dismutase and catalase activities were lower (p < 0.05) in gT-supplemented 
salmon as compared to the controls (Table 2). There were no differences in hepatic glutathione 
concentrations between the groups (Table 2). 
Table 2. Hepatic catalase (CAT) and superoxide dismutase (SOD) activities as well as 
glutathione concentrations (GSH) in Atlantic salmon fed either the control diet (C) or a diet 
enriched with gamma tocopherol (gT) a. 
Biomarker C gT p 
SOD (U/mg protein) 24.6 ±2.6 18.0 ± 1.2 0.04 
CAT (U/mg protein) 46.8 ±3.3 35.8 ± 2.1 0.01 
GSH (µmol/g) 2.1 ±0.1 1.9 ± 0.1 0.22 
a Values are means ± SE (n = 8). 
The fatty acid composition of the fish fillet reflected, by and large, the fatty acid composition of the 
diet. Interestingly, gT fed salmon exhibited a slightly higher n-3/n-6 ratio (p = 0.01) in comparison to 
the control animals (Table 3). The increase in the n-3/n-6 ratio was related to an increase in n-3 fatty 
acids since the amount of n-6 fatty acids remained unchanged. As far as n-3 fatty acids are concerned, 
gT supplementation somewhat increased C18:3n-3 in fish fillet (p = 0.02). However, the concentration 
of long chain PUFAs including EPA and DHA was not significantly different between the control and 
gT-fed fish. 
The liver fatty acid composition also reflected the dietary profile (Table 4). Gamma tocopherol 
promoted the accumulation of C18:0 (p < 0.001) together with a decrease of C18:1n-7 (p = 0.003) and 
C18:2n-6 (p = 0.008) fatty acids. No major changes were observed in terms of C20:4n-6, EPA and DHA. 
2.3. Gene Expression Analysis 
Different gene expression patterns were observed in salmon liver (Figure 1A) and pyloric caeca 
(Figure 1B). A general down-regulation of both long chain PUFA synthesis (Δ6Fad_a, Elov2) and 
lipid transport (CD36) as well as beta oxidation related genes (CPT1 and ACO) was observed in the 
liver of fish fed the diets enriched with gT (Figure 1A). Additionally, hepatic LXR expression was 
depressed (p < 0.01) in fish fed the gT rich diets, with no effect on PPARα, SERBP1 and Nrf2 
expression (Figure 1B). 
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Contrarily, in the pyloric caeca of fish fed gT there was an overall increase of genes encoding 
proteins involved in long chain PUFA synthesis (Δ5 Fad, Elov2 and Elov5a) (p < 0.01), and no 
response (CD36 and ACO) or a decrease (CPT1; p < 0.001) of lipid transport and beta oxidation 
related genes was evident (Figure 1B). As far as transcription factors are concerned, a significant  
down-regulation of LXR (p < 0.01) in gT fed fish was observed. Moreover, GPX4a expression was  
up-regulated (p < 0.01) due to gT in pyloric caeca (Figure 1B). 
Table 3. Fatty acid composition (g/100 g total fatty acid) of fillet from Atlantic salmon fed 
either a control diet (C) or a diet enriched with gamma tocopherol (gT) a. 
Fatty Acid C gT p 
C14:0 1.54 ±0.01 1.40 ±0.01 0.08 
C16:0 11.86 ±0.05 11.67 ±0.07 0.06 
C18:0 3.06 ±0.02 3.09 ±0.05 0.70 
∑SFA b 18.24 ±0.04 20.62 ±0.12 0.10 
C16:1n-7 1.86 ±0.04 1.80 ±0.01 0.17 
C18:1n-9 44.59 ±0.11 44.17 ±0.16 0.06 
C18:1n-7 1.87 ±0.04 1.82 ±0.06 0.53 
C20:1n-9 2.79 ±0.02 2.66 ±0.04 0.01 
∑MUFA c 52.32 ±0.11 51.74 ±0.18 0.02 
C18:2n-6 14.84 ±0.02 14.77 ±0.08 0.49 
C20:2n-6 1.15 ±0.01 1.05 ±0.02 0.01 
C20:4n-6 0.31 ±0.01 0.33 ±0.01 0.27 
∑ (n-6) d 16.82 ±0.03 16.82 ±0.07 0.99 
C18:3n-3 5.09 ±0.04 5.29 ±0.06 0.02 
C20:3n-3 0.75 ±0.02 0.81 ±0.03 0.12 
C20:5n-3 1.55 ±0.04 1.48 ± 0.05 0.33 
C22:5n-3 0.75 ± 0.01 0.91 ± 0.08 0.09 
C22:6n-3 3.94 ±0.08 4.13 ±0.14 0.30 
∑ (n-3) e 13.50 ±0.11 14.30 ±0.25 0.01 
n-3/n-6 0.80 ±0.01 0.85 ±0.01 0.01 
a Values are means ± SE (n = 8); b ∑SFA = sum of saturated fatty acids. Includes C14:0, C16:0, C17:0, C18:0 
and C20:0; c ∑MUFA = sum of monounsaturated fatty acids. Includes C16:1n-9, C16:1n-7, C17:1, C18:1n-9, 
C18:1n-7, C20:1n-9 and C22:1 isomers; d ∑ (n-6) = sum of n-6 fatty acids. Includes C18:2, C18:3, C20:2, 
C20:4 and C22:4; e ∑ (n-3) = sum of n-3 fatty acids. Includes C18:3, C18:4, C20:3, C20:4, C20:5, C22:5  
and C22:6. 
Table 4. Fatty acid composition (g/100 g total fatty acid) of liver from Atlantic salmon fed 
either a control diet (C) or a diet enriched with gamma tocopherol (gT) a. 
Fatty Acid C gT p 
C14:0 0.90 ±0.02 0.76 ±0.04 0.01 
C16:0 11.38 ±0.55 12.06 ±0.52 0.39 
C18:0 5.64 ±0.18 6.91 ±0.23 0.0008 
∑SFA b 18.24 ±0.55 20.62 ±0.65 0.01 
C16:1n-7 1.25 ±0.06 1.03 ±0.12 0.13 
C18:1n-9 36.19 ±1.47 33.29 ±2.53 0.34 
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Table 4. Cont. 
C18:1n-7 1.94 ±0.03 1.70 ±0.05 0.003 
C20:1n-9 3.84 ±0.19 3.59 ±0.19 0.37 
∑MUFA c 44.18 ±1.62 40.60 ±2.81 0.28 
C18:2n-6 10.18 ±0.29 8.89 ±0.30 0.008 
C20:2n-6 2.06 ±0.09 2.01 ±0.13 0.75 
C20:4n-6 1.81 ±0.14 2.36 ±0.31 0.13 
∑ (n-6) d 14.89 ±0.19 13.57 ±0.22 0.0005 
C18:3n-3 2.15 ±0.13 1.85 ±0.09 0.08 
C20:3n-3 2.41 ±0.13 2.67 ±0.20 0.3 
C20:5n-3 2.67 ±0.25 2.75 ±0.32 0.85 
C22:5n-3 1.12 ±0.07 1.19 ±0.15 0.65 
C22:6n-3 13.03 ±0.92 15.39 ±1.69 0.24 
∑ (n-3) e 22.35 ±1.22 24.89 ±2.16 0.32 
n-3/n-6 1.50 ±0.08 1.83 ±0.14 0.08 
a Values are means ± SE (n = 8); b ∑SFA = sum of saturated fatty acids. Includes C14:0, C16:0, C17:0, C18:0 
and C20:0; c ∑MUFA = sum of monounsaturated fatty acids. Includes C16:1n-9, C16:1n-7, C17:1, C18:1n-9, 
C18:1n-7, C20:1n-9 and C22:1 isomers; d ∑ (n-6) = sum of n-6 fatty acids. Includes C18:2, C18:3, C20:2, 
C20:4 and C22:4; e ∑ (n-3) = sum of n-3 fatty acids. Includes C18:3, C18:4, C20:3, C20:4, C20:5, C22:5  
and C22:6. 
Figure 1. mRNA levels of genes encoding proteins centrally involved in fatty acid 
transport, synthesis and metabolism in salmon liver (A); and pyloric caeca (B). Relative gene 
expression values are shown as the fold change of the gamma tocopherol (gT) diet relative 
to the control diet (C) which was set to be 1.0 (n = 8 fish per group). Bars indicate the 95% 
confidence interval (Fold change up-Fold change low). (* p < 0.05; ** p < 0.01;  
*** p < 0.001). 
 
(A) 
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Marine functional foods may supply the consumer with macro- and micronutrients as well as 
nutraceuticals, thereby positively affecting cardiovascular health. In general, seafood and especially 
oily fish, such as Atlantic salmon, seem to be attractive sources to deliver fat soluble vitamins such as  
tocopherols since Vitamin E absorption is positively correlated with the lipid level of the diet. 
Furthermore, it has been suggested that tocopherols consumed within a complex food matrix may 
prevent cardiovascular disease more efficiently as compared to purified Vitamin E supplements [18]. 
Our data indicate that feeding Atlantic salmon with gT-rich diets resulted in a significant increase in 
gT concentrations in fish fillet, thereby improving its nutritional value. Thus, Atlantic salmon could be 
considered as a potential marine functional source of gT for human nutrition. However, future human 
trials (e.g., bioavailability studies, intervention studies) are required to test the hypothesis whether the 
consumption of gT-rich Atlantic salmon results in increased plasma levels of gT that may lead to 
potential anti-inflammatory and anti-atherogenic effects. 
Interestingly, high dietary gT concentrations did not impair alpha tocopherol tissue levels. Thus, 
under the conditions investigated, no antagonistic interaction between gamma and alpha tocopherol 
was evident. Contrarily, high dietary alpha tocopherol concentrations have been reported to decrease 
gT tissue concentrations [5]. This is possibly related to the induction of cytochrome P450 enzymes which 
are involved in the metabolism of tocopherols and preferentially degrade the desmethyl vitamers [19]. 
Furthermore, we observed lower hepatic catalase and superoxide dismutase activities which may be 
indicative of an overall lowered oxidative stress level in the gT-fed salmon. Dietary gT supplementation 
significantly decreased MDA concentration in fish fillet. MDA is a biomarker of lipid peroxidation and 
impairs the sensory quality of oily fish [17]. Current as well as literature data [20] suggest that dietary gT 
could possibly improve the sensory quality of oily fish by reducing lipid peroxidation. In this context, 
future studies are needed to evaluate whether gT affects the shelf life of Atlantic salmon. 
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The enrichment of fat soluble pro-vitamins and vitamins into the food matrix is a common practice 
in aquaculture. However, the transfer of micronutrients including Vitamin E from the diet into the 
animal tissue is always accompanied by a loss in assimilation. In order to quantify the apparent 
Vitamin E absorption, digestibility experiments need to be conducted which was beyond the scope of 
our study. Furthermore, Vitamin E transfer may be experimentally determined by its whole body 
retention. In order to do so, Vitamin E levels need to be quantified in all tissues at the beginning and 
the end of a feeding trial. However, within this study Vitamin E was only determined in fillet and liver 
at the end of the study. Thus, it was not possible to pinpoint the exact Vitamin E retention. However, 
analyzed alpha and gamma tocopherol levels in liver and fillet suggest that the tissue retention of alpha 
tocopherol was higher as compared to gamma tocopherol which is in line with literature data [14]. In 
terms of alpha tocopherol, it has been suggested that around 40% of dietary alpha tocopherol is 
retained in the fillet of Atlantic salmon [14]. Since in the fillet of our salmon following dietary 
supplementation, the gamma tocopherol concentration was 2.8 fold lower as compared to alpha 
tocopherol a transfer efficiency of around 15% may be assumed. 
Irrespective of a loss of retention, our experimental approach leads to a marine product rich in both, 
omega-3 fatty acids as well as alpha and gamma tocopherol. In this context it has been suggested that 
the consumption of 200 g Atlantic salmon would be sufficient to fulfill roughly 30% of the dietary 
Vitamin E recommendation [5]. Furthermore, it should be taken into account that oily fish does not 
only provide omega 3 fatty acids but is also an important source of protein, minerals and trace elements. 
Besides its antioxidant activity, Vitamin E also plays an important role in signal transduction [21]. 
Both isoforms alpha and gamma tocopherol seem to affect lipid homeostasis in different ways. Studies 
in hepatocytes and Caco-2 cells have shown a decrease in cholesterol synthesis and secretion due to 
tocopherols via down-regulation of LXR, BCA1, ABCG1, SREBP1c or SREBP-2 transcription  
factors [22,23]. Additionally, there is evidence that alpha tocopherol can modulate the expression and 
activity of Δ9 and Δ6 fad [22,24]. In the present study, salmon fed the gT-enriched diets exhibited a 
significant hepatic down-regulation of different genes encoding proteins involved in lipid transport 
(CD36) and beta oxidation (CPT1 and ACO) as well as long chain PUFA synthesis (Δ6fad_a and 
elov2) which was mediated by decreased LXR gene expression. Together with the observed trend 
towards an increase of C18:3n-3 in the fillet, the decrease in liver C18:1n-7, C18:2n-6 and the 
accumulation of C18:0 may be the result of an overall down-regulation of lipid transport and beta 
oxidation as well as a decreased elongation and desaturation of C18:0. There are several molecular 
mechanisms by which tocopherol or its metabolites may affect gene expression and enzyme  
function [21,25]. The structural changes that tocopherol promotes when it is embedded in the membrane 
can affect lipid homeostasis [21]. Moreover, gT exerts different structural influence on the membrane 
than alpha tocopherol [26]. Studies in fish also suggest an indirect effect of Vitamin E on long chain 
PUFA synthesis by altering the cellular redox status [27]. Therefore, the efficient accumulation of both 
alpha and gamma tocopherol in salmon liver and lowered oxidative stress levels might have 
contributed to the changes observed in gene expression. 
Similarly, CPT1 and transcription factor gene expression was down-regulated in the pyloric caeca of 
salmon fed gT. However, Δ5 fad, Elov2 and Elov5a expression was increased. Different gene expression 
patterns of elongases and desaturases have been reported in the liver and pyloric caeca of salmon fed 
vegetable oils [28,29]. Additionally, the expression of the antioxidant enzyme GPX4a, which reduces 
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phospholipid hydroperoxides [30], in the pyloric caeca of fish fed gT suggests a protective role of gT in 
lipid peroxidation. Moreover, Malandrakis et al. [31] suggested that the GPx status, which was improved 
by gamma tocopherol in our study, might be considered as an important indicator of fish welfare. 
4. Experimental Section 
4.1. Animals and Diets 
A feeding trial with 120 Atlantic salmon post-smolt was performed at the Skretting Aquaculture 
Research Center (ARC) fish trial station (Lerang Research Station, Jorpeland, Norway). All 
experimental procedures were performed according to the Norwegian Animal Research Authority 
(FDU) guidelines. Fish with an initial average weight of 137.4 ± 1 g were randomly assigned to four  
1 m deep × 1 m diameter circular tanks supplied with sea water and fed one of the two experimental 
diets for 16 weeks. Water temperature over the experimental period averaged 12.2 ± 0.2 °C. A basal 
control diet (C) was formulated to meet salmon nutrient recommendations [32] by using low fishmeal 
and fish oil concentrations (Table 5). The gamma tocopherol diet (gT) was the basal diet supplemented 
with 0.6 g/kg of D-γ-tocopherol (Chromadex). The analyzed composition of gT was 15 ppm and  
170 ppm for the C and the gT diets, respectively. The dietary treatments were prepared at Skretting 
ARC pilot plant (Stavanger, Norway), as extruded, sinking 4 mm pellets. 
4.2. Sampling 
At the beginning, after formalin treatment and at the end of the experiment, all fish were 
individually weighed and measured for growth monitoring. For the final sampling, fish were deprived 
of feed for 12 h and then anesthetized and killed by a blow to the head. Four fish per tank (n = 8 
per·diet) were selected to obtain individual samples of liver, fillet and plasma. Tissues were collected, 
snap frozen and stored at −80 °C for fatty acid, enzyme, tocopherol and MDA analyses. Approximately, 
1 g of liver and mucosal scrapings from pyloric caeca were placed in RNA later and stored at −80 °C 
for gene expression analysis. 
Table 5. Ingredients and analyzed chemical composition of the basal diet. 
Ingredients  As Fed Basis (g/kg) 
Wheat 50.0 
Wheat gluten 168.1 
Faba beans dehulled 93.8 
Soy protein concentrate 310.0 
Fishmeal NA 100.0 
Palm oil 27.1 
Linseed oil 11.7 
Rapeseed oil 163.0 
Fish oil NA 38.9 
Astaxanthin 10% 0.4 
Vitamin and mineral mix 37.1 
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Table 5. Cont. 
Analyzed composition 
Moisture, % 6.6 
Total fat, % 26.7 
Crude protein, % 45.6 
Ash, % 4.6 
α-tocopherol (ppm) 192 
γ-tocopherol (ppm) 15 
Fatty acids  Total fatty acids (g/100 g) 
C16:0 10.35 
∑SFA a 15.27 
C18:1n-9 41.17 
∑MUFA b 49.10  
C18:2n-6 17.39 




∑ (n-3) 12.45  
n-3/n-6 0.69 
a ∑SFA = sum of saturated fatty acids; b ∑MUFA = sum of monounsaturated fatty acids. 
4.3. Chemical and Enzyme Analysis 
Feeds were analyzed for moisture, total fat, protein and ash by using in-house near-infrared 
reflectance (NIR) methodology at the Skretting ARC laboratory as previously described by [33]. Fatty 
acid analysis of the experimental diets was conducted by using gas chromatography and flame 
ionization detection [34]. Alpha and gamma tocopherol isomers of the experimental diets were 
analyzed using HPLC according to method [35]. Alpha and gamma tocopherols in salmon fillets and 
liver were extracted and quantified according to Faizan et al. [5]. Briefly, the tissues were 
homogenized in ethanol with ascorbic acid and KOH. After saponification, butylhydroxytoluol in 
ethanol and n-hexane were added and the organic phase was dried and dissolved in methanol. The 
separation of alpha and gamma tocopherol was performed by HPLC (Jasco GmbH Deutschland, 
Gross-Umstadt, Germany) on a Waters Spherisorb ODS-2 column (100 mm × 4.6 mm; 3 μm) using 
methanol/water (98:2, v/v) as mobile phase. The fluorescence detector was set to an excitation 
wavelength of 296 nm and emission wavelength of 325 nm. 
Tissue lipids were extracted with dichloromethane-methanol (8:2) and fatty acids were methylated 
in the presence of sulphuric acid following the method of Segura and López-Bote [36]. Fatty acid 
methyl esters were then analyzed using a gas chromatograph (HP 6890 Series GC System) equipped 
with a flame ionization detector. Lipid peroxidation products in salmon fillets were determined as 
MDA concentrations by HPLC analysis according to Faizan et al. [17]. Briefly, fish tissue was 
homogenized in 1% sulfuric acid, addition of 0.2 volumes 6M NaOH was followed by a 30 min 
incubation at 60 °C, proteins were precipitated by adding perchloric acid and after centrifugation the 
supernatant was incubated with 2,4-dinitrophenylhydrazine and injected into a Jasco HPLC system. 
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Using an isocratic mode with a mobile phase consisting of 0.2% acetic acid (v/v) in water/acetonitrile 
(42:58, v/v) the samples were separated on a Supelco INC water spherisorb ODS2 column (10 cm × 4.6 mm, 
3 μm). MDA was analyzed at 310 nm. 
Glutathione (GSH) was detected according to a modified method described previously [37]. Briefly, 
tissues were homogenized in 0.25 M sucrose, 3 mM EDTA, 10 mM Tris buffer pH 7.4 in bidest. water, 
Immediately after homogenization, the samples were mixed with equal amounts of ice-cold 10% (w/v) 
meta-phosphoric acid, incubated on ice and centrifuged before the clear supernatants were stored until 
analysis or analyzed directly by HPLC with a Kinetex C18 column (100 × 4.6 mm, 2.6 μm; 
Phenomenex, Aschaffenburg, Germany) and a 50 mM NaH2PO4 (adjusted to pH 3.0 with 
orthophosphoric acid) mobile phase. HPLC-EC detection of GSH was performed using an ESA 
(Chelmsford, MA, USA) colorimetric detector [38]. 
Hepatic superoxide dismutase was determined according to Marklund and Marklund [39] by 
measuring the inhibition of pyrogallol auto-oxidation spectrophotometrically. Catalase activity was 
measured according to Johansson and Borg [40] by measuring the absorption at 540 nm after adding 
methanol, hydrogen peroxide and purbald to the samples. For both assays, the supernatants from 
centrifuged tissues that had been homogenized in ice-cold PBS were used. 
4.4. Gene Expression Analysis 
Salmon liver and pyloric caecum RNA extraction and quality analysis was performed as indicated 
by Ipharraguerre et al. [41]. Reverse transcription was performed using the SuperScript VILO Master 
Mix (Invitrogen, Carlsbad, CA, USA) following the manufacturer’s guidelines. qRT-PCR was carried 
out using the SYBR® Green Master Mix (Applied Biosystems, Foster City, CA, USA) in a 7300 Real 
Time PCR System (Applied Biosystems, Foster City, CA, USA). Primers and PCR conditions for 
salmon housekeeping genes β-actin and eukaryotic translation elongation factor 1 alpha (EF-1α) as 
well as Δ6 fad, carnitine palmitoyltransferase 1 (CPT1), and acyl CoA oxidase (ACO) were assayed as 
described by Leaver et al. [42], Δ5 fad and elongase 2 (Elov2) according to Morais et al. [28], Elov5a 
and LXR according to Minghetti et al. [43], CD36 according to Schiller et al. [44] and glutathione 
peroxidase 4a and b (GPX4a and GPX4b) according to Wang et al. [30] (Table 6). 
Primers for the expression analysis of sterol receptor binding protein 1 (SREBP1), nuclear  
factor-like 2 (Nrf2), and PPARα were designed from sequences NM_001195818, BT059007.1 and 
AM230809.1, respectively, using Primer Express Software (Applied Biosystems, CA, USA; Table 2). 
The concentration and annealing temperatures for SREBP1 were 0.2 μM and 60 °C; 0.4 µM and 62 °C 
for PPARα; and 0.2 μM and 60 °C for Nrf2. 
4.5. Statistical Analysis 
Differences between means induced by gT relative to the C diet were detected through a t-test 
analysis using the PROC TTEST from SAS (release 9.2, SAS Institute Inc., Cary, NC, USA) [45]. For 
genes displaying efficiencies different from 2 (E ≠ 2), Ct values were adjusted according to the model 
described by Steibel et al. [46]. The geometric mean of the reference genes β-actin and EF-1α was 
used to correct Ct values of target genes [47]. 
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Table 6. Genes and forward (Fw) and reverse (Rv) primers used for gene expression 
analysis by qRT-PCR. 
Genes Primer Sequence Fw Primer Sequence Rv Reference 
Δ6fad_a CCCCAGACGTTTGTGTCAG CCTGGATTGTTGCTTTGGAT [42] 
ACO AAAGCCTTCACCACATGGAC TAGGACACGATGCCACTCAG [42] 
β-actin ACATCAAGGAGAAGCTGTGC GACAACGGAACCTCTCGTTA [42] 
EF-1α CTGCCCCTCCAGGACGTTTCAA CACCGGGCATAGCCGATTCC [42] 
Δ5 fad GTGAATGGGGATCCATAGCA AAACGAACGGACAACCAGA [28] 
Elov2 CGGTACAAAATGTGCTGGT TCTGTTTGCCGATAGCCATT [28] 
Elov5a ACAAGACAGGAATCTCTTTCAGATTAA TCTGGGGTTACTGTGCTATAGTGTAC [43] 
LXR GCCGCCGCTATCTGAAATCTG CAATCCGGCACCAATCTGTAGG [43] 
CD36 GGATGAACTCCCTGCATGTGA TGAGGCCAAAGTACTCGTCGA [44] 
SREBP1 CACTACTAGCCCCATGTTTTGATTG CAGCCACTCTCTAAACACACCAA  
PPARα GCTCCTTGGATGTCCCTGAGT GCATCTAGAACGGTGGATCCTT  
Nrf2 GGTTTCCAGACTTCTCTCTCAGTGT GAACATGGCAAGACCGAGCC  
GPX4a GTACGCTGAGAAAGGTTTACGC TTGATGCCATTTCCCAGG [30] 
GPX4b ATCACCAACGTTGCCTCTAAAT CCTTGATTTCCACCTCTGTACC [30] 
CPT1 CCTGTACCGTGGAGACCTGT CAGCACCTCTTTGAGGAAGG [42] 
5. Conclusions 
The present findings suggest that salmon fillet can be enriched with gT when provided in the feed. 
Moreover, no antagonistic interaction between gamma and alpha tocopherol was observed in salmon 
tissues after high dietary gT feeding. This seems to improve both the nutritional value, with higher 
tocopherol and a slight increase of n-3 concentrations, and the sensory quality of Atlantic salmon. 
Moreover, gT increases fish GPx status and hence its welfare. Overall, Atlantic salmon may be an 
important marine functional source capable of improving gT supply in humans. 
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